FOSTER CITY, Calif. (AP) — FOSTER CITY, Calif. (AP) — Gilead Sciences Inc. (GILD) on Thursday reported third-quarter net income of $2.43 billion.
On a per-share basis, the Foster City, California-based company said it had net income of $1.94. Earnings, adjusted for non-recurring costs, were $2.55 per share.
The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of $2.17 per share.
The HIV and hepatitis C drugmaker posted revenue of $8.3 billion in the period, also topping Street forecasts. Four analysts surveyed by Zacks expected $7.81 billion.
Gilead expects full-year results to range from a loss of $1.20 per share to a loss of 85 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GILD at https://www.zacks.com/ap/GILD
